Elevance Health director granted 563 deferred units

SCHULMAN AMY W reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

SCHULMAN AMY W reported acquisition or exercise transactions in this Form 4 filing.

Elevance Health director Amy W. Schulman received an equity award of 563 deferred stock units of common stock under the company’s Board of Directors Compensation Program. This grant increased her directly held equity-related position to 781 shares-equivalent, payable in common stock at a future date tied to service on the board.

Insider Trade Summary

Grant/Award: 563 shares

Grant/Award 1 txn

Insider SCHULMAN AMY W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	563	$0.00	$0.00

Holdings After Transaction: Common Stock — 781 shares (Direct)

Footnotes (2)

1. F1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
2. F2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Key Figures

Deferred stock units granted: 563 units Holdings after transaction: 781 shares-equivalent Transaction price per unit: $0.0000 +1 more

4 metrics

Deferred stock units granted 563 units Director compensation grant on 2026-05-13

Holdings after transaction 781 shares-equivalent Total common stock-related position following award

Transaction price per unit $0.0000 Equity award, not a market purchase

Transaction code A (Grant, award, or other acquisition) Non-derivative acquisition of deferred stock units

Key Terms

Deferred stock units, Board of Directors Compensation Program, Board of Directors Deferred Compensation Plan

3 terms

Deferred stock units financial

"Deferred stock units accrued under the Elevance Health, Inc. Board of Directors Compensation Program."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Board of Directors Compensation Program financial

"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."

Board of Directors Deferred Compensation Plan financial

"unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elevance Health (ELV) director Amy Schulman report on this Form 4?

Amy W. Schulman reported receiving an award of 563 deferred stock units of Elevance Health common stock. These units are part of the Board compensation program and increase her equity-related holdings to 781 shares-equivalent after the grant.

How many Elevance Health (ELV) shares does Amy Schulman hold after this grant?

After the award, Amy Schulman beneficially owns 781 shares-equivalent of Elevance Health common stock. This reflects the addition of 563 deferred stock units granted as director compensation, with no open-market purchases or sales disclosed in this filing.

Was Amy Schulman buying or selling Elevance Health (ELV) stock in the market?

No open-market trades were reported. The Form 4 shows a grant of 563 deferred stock units as compensation, coded as an acquisition. The transaction price is listed as zero, indicating it was an award rather than a market purchase.

What are the key terms of Amy Schulman’s deferred stock units at Elevance Health (ELV)?

The deferred stock units are payable in Elevance Health common stock. Payment occurs on the earlier of five years from grant or when she leaves the board, unless she elects a later distribution date under the Board Deferred Compensation Plan.

Is this Elevance Health (ELV) Form 4 transaction part of director compensation?

Yes. The filing states the 563 deferred stock units accrued under Elevance Health’s Board of Directors Compensation Program. This indicates the award is standard director compensation rather than a discretionary market trade by Amy Schulman.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHULMAN AMY W

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		563(1)(2)	A	$0	781	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)